Advertisement
Advertisement
ETON
Eton Pharmaceutcials, Inc. Common Stock
50.00
USDSponsored
-0.02
-0.04%
Oct 23, 15:59 UTC -4
Closed
After-Market
49.44
-0.56
-1.13%
Eton Pharmaceutcials, Inc. Common Stock (ETON) Earnings
ETON Earnings Reports
Positive Surprise Ratio
ETON beat 13 of 29 last estimates.
45%
Next Report
Date of Next Report
Nov 05, 2026
Estimate for Q3 26 (Revenue/ EPS)
$39.64M
/$0.31
Implied change from Q2 26 (Revenue/ EPS)
+5.46%
/-11.43%
Implied change from Q3 25 (Revenue/ EPS)
+76.50%
/-542.86%
Eton Pharmaceutcials, Inc. Common Stock earnings per share and revenue
On Aug 13, 2026, ETON reported earnings of 0.35 USD per share (EPS) for Q2 26, beating the estimate of 0.10 USD, resulting in a 226.80% surprise. Revenue reached 37.59 million, compared to an expected 27.66 million, with a 35.89% difference. The market reacted with a +44.26% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of 0.31 USD, with revenue projected to reach 39.64 million USD, implying an decrease of -11.43% EPS, and increase of 5.46% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Tiziana Life Sciences Ltd. Common Shares
Report Date
Oct 16, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.10
Surprise
-22.55%
argenx SE - ADR
Report Date
Oct 22, 2026 For Q3 26
Estimate
$8.19
Actual
$7.80
Surprise
-4.84%
QIAGEN N.V.
Report Date
Oct 21, 2026 For Q3 26
Estimate
$0.63
Actual
$0.65
Surprise
+2.43%
Nurix Therapeutics, Inc. Common stock
Report Date
Oct 12, 2026 For Q3 26
Estimate
-$0.61
Actual
$4.73
Surprise
+871.74%
FAQ
What were Eton Pharmaceutcials, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Eton Pharmaceutcials, Inc. Common Stock reported EPS of $0.35, beating estimates by 226.8%, and revenue of $37.59M, 35.89% above expectations.
How did the market react to Eton Pharmaceutcials, Inc. Common Stock's Q2 2026 earnings?
The stock price moved up 44.26%, changed from $40.80 before the earnings release to $58.86 the day after.
When is Eton Pharmaceutcials, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 05, 2026.
What are the forecasts for Eton Pharmaceutcials, Inc. Common Stock's next earnings report?
Based on 4
analysts, Eton Pharmaceutcials, Inc. Common Stock is expected to report EPS of $0.31 and revenue of $39.64M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.